Cadila Healthcare board to consider audited financial results

25 Apr 2016 Evaluate

Cadila Healthcare has informed that a meeting of the Board of Directors of the Company will be held on May 13, 2016, to consider & approve the audited financial results for the year ended on March 31, 2016. Further, as per Code of Conduct for prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window will remain closed from May 02, 2016 to May 15, 2016 for all Directors and designated officers of the Company.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

881.10 13.30 (1.53%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1391.20
Zydus Lifesciences 881.10
Lupin 2178.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×